DE69330643T2 - Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon - Google Patents
Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davonInfo
- Publication number
- DE69330643T2 DE69330643T2 DE69330643T DE69330643T DE69330643T2 DE 69330643 T2 DE69330643 T2 DE 69330643T2 DE 69330643 T DE69330643 T DE 69330643T DE 69330643 T DE69330643 T DE 69330643T DE 69330643 T2 DE69330643 T2 DE 69330643T2
- Authority
- DE
- Germany
- Prior art keywords
- dothelium
- glycoprotein
- monoclonal antibody
- specifically binds
- vascularized tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/855—Proteins from animals other than mammals or birds
- Y10S530/857—Fish; fish eggs; shell fish; crustacea
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/976,405 US5342757A (en) | 1992-11-13 | 1992-11-13 | Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof |
PCT/US1993/010773 WO1994011023A1 (en) | 1992-11-13 | 1993-11-09 | Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69330643D1 DE69330643D1 (de) | 2001-09-27 |
DE69330643T2 true DE69330643T2 (de) | 2002-07-04 |
Family
ID=25524065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69330643T Expired - Lifetime DE69330643T2 (de) | 1992-11-13 | 1993-11-09 | Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon |
Country Status (12)
Country | Link |
---|---|
US (2) | US5342757A (de) |
EP (1) | EP0673255B1 (de) |
JP (1) | JP3541296B2 (de) |
AT (1) | ATE204480T1 (de) |
AU (1) | AU671884B2 (de) |
CA (1) | CA2149120C (de) |
DE (1) | DE69330643T2 (de) |
DK (1) | DK0673255T3 (de) |
ES (1) | ES2161751T3 (de) |
GR (1) | GR3036906T3 (de) |
PT (1) | PT673255E (de) |
WO (1) | WO1994011023A1 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6749853B1 (en) * | 1992-03-05 | 2004-06-15 | Board Of Regents, The University Of Texas System | Combined methods and compositions for coagulation and tumor treatment |
US6093399A (en) * | 1992-03-05 | 2000-07-25 | Board Of Regents, The University Of Texas System | Methods and compositions for the specific coagulation of vasculature |
US5877289A (en) * | 1992-03-05 | 1999-03-02 | The Scripps Research Institute | Tissue factor compositions and ligands for the specific coagulation of vasculature |
US5776427A (en) * | 1992-03-05 | 1998-07-07 | Board Of Regents, The University Of Texas System | Methods for targeting the vasculature of solid tumors |
US6004554A (en) * | 1992-03-05 | 1999-12-21 | Board Of Regents, The University Of Texas System | Methods for targeting the vasculature of solid tumors |
US6004555A (en) * | 1992-03-05 | 1999-12-21 | Board Of Regents, The University Of Texas System | Methods for the specific coagulation of vasculature |
US6036955A (en) * | 1992-03-05 | 2000-03-14 | The Scripps Research Institute | Kits and methods for the specific coagulation of vasculature |
US5965132A (en) * | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
ATE327330T1 (de) * | 1994-03-08 | 2006-06-15 | Sloan Kettering Inst Cancer | Rekombinante humanisierte antikörper gegen fb5 |
US5536641A (en) * | 1994-05-17 | 1996-07-16 | Memorial Sloane Kittering Cancer Center | Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells |
US6548663B1 (en) | 1998-03-31 | 2003-04-15 | Bristol-Myers Squibb Pharma Company | Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
EA200001007A1 (ru) | 1998-03-31 | 2001-04-23 | Дюпон Фармасьютикалз Компани | Фармацевтические препараты для визуализации ангиогенных расстройств |
US6537520B1 (en) | 1998-03-31 | 2003-03-25 | Bristol-Myers Squibb Pharma Company | Pharmaceuticals for the imaging of angiogenic disorders |
US6524553B2 (en) | 1998-03-31 | 2003-02-25 | Bristol-Myers Squibb Pharma Company | Quinolone vitronectin receptor antagonist pharmaceuticals |
US6569402B1 (en) | 1998-12-18 | 2003-05-27 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
US6511649B1 (en) | 1998-12-18 | 2003-01-28 | Thomas D. Harris | Vitronectin receptor antagonist pharmaceuticals |
AU2371400A (en) | 1998-12-18 | 2000-07-03 | Du Pont Pharmaceuticals Company | Vitronectin receptor antagonist pharmaceuticals |
JP2002532440A (ja) | 1998-12-18 | 2002-10-02 | デュポン ファーマシューティカルズ カンパニー | ビトロネクチン受容体拮抗剤薬剤 |
US6794518B1 (en) * | 1998-12-18 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
EP1307557A2 (de) * | 2000-08-02 | 2003-05-07 | The Johns Hopkins University | Expressionsmuster von endothelzellen |
US7731648B2 (en) | 2001-07-25 | 2010-06-08 | Aduro Biotech | Magnetic nanoscale particle compositions, and therapeutic methods related thereto |
US7951061B2 (en) | 2001-07-25 | 2011-05-31 | Allan Foreman | Devices for targeted delivery of thermotherapy, and methods related thereto |
US7074175B2 (en) | 2001-07-25 | 2006-07-11 | Erik Schroeder Handy | Thermotherapy via targeted delivery of nanoscale magnetic particles |
US6997863B2 (en) | 2001-07-25 | 2006-02-14 | Triton Biosystems, Inc. | Thermotherapy via targeted delivery of nanoscale magnetic particles |
EP2365004B1 (de) * | 2002-06-21 | 2016-01-06 | Johns Hopkins University School of Medicine | Membranassoziierte Tumorendothel-Marker |
JP4928259B2 (ja) * | 2003-03-04 | 2012-05-09 | キリンホールディングス株式会社 | 内皮細胞特異的抗体およびその使用 |
CA2590583A1 (en) * | 2004-12-03 | 2006-06-08 | Morphotek, Inc. | Use of endosialin binding proteins to isolate endosialin positive cells |
AU2006241235B2 (en) * | 2005-04-22 | 2012-04-05 | Eisai, Inc. | Antibodies with immune effector activity and that internalize in endosialin-positive cells |
PL2137217T3 (pl) | 2007-04-05 | 2014-08-29 | Eisai Inc | Sposoby hamowania wiązania endosialiny z ligandami |
WO2010118203A2 (en) * | 2009-04-09 | 2010-10-14 | Morphotek, Inc. | Endosialin binding molecules |
SE535982C2 (sv) * | 2009-12-15 | 2013-03-19 | Theravac Pharmaceuticals Ab | Ett nytt vaccin som angriper tumörkärl som ett effektivt redskap i tumörterapi |
EP2621946A1 (de) | 2010-09-29 | 2013-08-07 | Morphotek, Inc. | Manipulierte humanes endosialin-exprimierende nager |
EP3543258B1 (de) * | 2012-03-30 | 2023-09-13 | Eisai R&D Management Co., Ltd. | Diagnostische tem-1-antikörper |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE327330T1 (de) * | 1994-03-08 | 2006-06-15 | Sloan Kettering Inst Cancer | Rekombinante humanisierte antikörper gegen fb5 |
-
1992
- 1992-11-13 US US07/976,405 patent/US5342757A/en not_active Expired - Lifetime
-
1993
- 1993-11-09 AU AU55965/94A patent/AU671884B2/en not_active Expired
- 1993-11-09 ES ES94901335T patent/ES2161751T3/es not_active Expired - Lifetime
- 1993-11-09 JP JP51227494A patent/JP3541296B2/ja not_active Expired - Lifetime
- 1993-11-09 WO PCT/US1993/010773 patent/WO1994011023A1/en active IP Right Grant
- 1993-11-09 DE DE69330643T patent/DE69330643T2/de not_active Expired - Lifetime
- 1993-11-09 DK DK94901335T patent/DK0673255T3/da active
- 1993-11-09 CA CA002149120A patent/CA2149120C/en not_active Expired - Lifetime
- 1993-11-09 EP EP94901335A patent/EP0673255B1/de not_active Expired - Lifetime
- 1993-11-09 PT PT94901335T patent/PT673255E/pt unknown
- 1993-11-09 AT AT94901335T patent/ATE204480T1/de active
-
1994
- 1994-03-30 US US08/221,033 patent/US5437865A/en not_active Expired - Lifetime
-
2001
- 2001-10-16 GR GR20010401776T patent/GR3036906T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1994011023A1 (en) | 1994-05-26 |
JP3541296B2 (ja) | 2004-07-07 |
DK0673255T3 (da) | 2001-12-10 |
EP0673255B1 (de) | 2001-08-22 |
JPH08505764A (ja) | 1996-06-25 |
US5437865A (en) | 1995-08-01 |
DE69330643D1 (de) | 2001-09-27 |
CA2149120C (en) | 2005-09-27 |
EP0673255A4 (de) | 1996-08-21 |
PT673255E (pt) | 2002-02-28 |
ATE204480T1 (de) | 2001-09-15 |
US5342757A (en) | 1994-08-30 |
EP0673255A1 (de) | 1995-09-27 |
AU671884B2 (en) | 1996-09-12 |
CA2149120A1 (en) | 1994-05-26 |
ES2161751T3 (es) | 2001-12-16 |
AU5596594A (en) | 1994-06-08 |
GR3036906T3 (en) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69330643T2 (de) | Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon | |
Capra et al. | Light chain sequences of human IgM cold agglutinins | |
ATE223229T1 (de) | Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren | |
KR960704576A (ko) | CD40에 대한 항체(Antibodies to CD40) | |
WO1998057994A3 (en) | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria | |
ES2115596T3 (es) | Recombinados inmunoconjugados para terapias que comprenden interleucina-2. | |
KR930703008A (ko) | 복합된 특이성 융합 단백질 | |
ATE512224T1 (de) | Rekonstituierter menschlicher anti-hm.1 antikörper | |
ATE177758T1 (de) | Synthetische peptide, antikörper dagegen und ihre verwendung | |
ES8800274A1 (es) | Un procedimiento para la preparacion de un polipeptido-c-terminal p21ras | |
GB9009106D0 (en) | Processes and intermediates for synthetic antibody derivatives | |
FI873410A (fi) | Kahden uuden hybridooman tuottamia apolipoproteiini-B-spesifisiä monoklonaalisia vasta-aineita | |
ES2149159T3 (es) | Proteinas de fusion con contenido en anticuerpos monoclonales, enlazador- y beta-glucuronidasa, destinadas a la activacion de profarmacos, su preparacion y utilizacion. | |
CA2126182A1 (en) | Humanized antibodies reactive with gpiib/iiia | |
CA2137280A1 (fr) | Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications | |
ATE230418T1 (de) | Monoklonaler antikörper gegen das humane mx- protein mxa | |
ATE222767T1 (de) | Isolierte proteine mit 55-75 kda, die an das prion-protein anbinden | |
NO972522L (no) | Monoklonale antistoffer med immunoundertrykkende aktivitet | |
DE59608073D1 (de) | Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid | |
DK0513565T3 (da) | Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse | |
DE69010897T2 (de) | Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin. | |
ATE231167T1 (de) | Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper | |
IT1243280B (it) | Anticorpi monoclonali specifici per il fattore piastrinico 4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |